Results of prostate cancer screening in a unique cohort at 19 yr of follow-up
DF Osses, S Remmers, FH Schröder, T van der Kwast… - European urology, 2019 - Elsevier
We assessed the effect of screening in the European Randomized study of Screening for
Prostate Cancer (ERSPC) Rotterdam pilot 1 study cohort with men randomized in 1991 …
Prostate Cancer (ERSPC) Rotterdam pilot 1 study cohort with men randomized in 1991 …
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial
F Labrie, B Candas, A Dupont, L Cusan… - The …, 1999 - Wiley Online Library
Abstract BACKGROUND The 46,193 men aged 45 to 80 years registered in the electoral roll
of Quebec City and its Metropolitan area were randomized in November 1988 between …
of Quebec City and its Metropolitan area were randomized in November 1988 between …
European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies
FH Schröder, LJ Denis, W Kirkels, HJ De Koning… - Cancer, 1995 - Wiley Online Library
Background. The feasibility of screening and early detection of prostate cancer are
controversial issues at this time. To conduct a randomized screening study with prostate …
controversial issues at this time. To conduct a randomized screening study with prostate …
Results from 22 years of followup in the Göteborg randomized population-based prostate cancer screening trial
M Frånlund, M Månsson, RA Godtman, G Aus… - The Journal of …, 2022 - auajournals.org
Purpose: Our goal was to analyze results from 22 years of followup in the Göteborg
randomized prostate cancer (PC) screening trial. Materials and Methods: In December 1994 …
randomized prostate cancer (PC) screening trial. Materials and Methods: In December 1994 …
Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial
F Labrie, B Candas, L Cusan, JL Gomez… - The …, 2004 - Wiley Online Library
PURPOSE This clinical trial is aimed at evaluating the impact of prostate cancer screening
on cancer‐specific mortality. SUBJECTS AND METHODS Forty‐six thousand four hundred …
on cancer‐specific mortality. SUBJECTS AND METHODS Forty‐six thousand four hundred …
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer—results from a prospective, population-based randomized …
G Aus, S Bergdahl, P Lodding, H Lilja, J Hugosson - European urology, 2007 - Elsevier
OBJECTIVES: Randomized controlled trials are currently conducted to assess whether the
mortality from prostate cancer is reduced by early detection with the use of prostate-specific …
mortality from prostate cancer is reduced by early detection with the use of prostate-specific …
Second round results of the Finnish population-based prostate cancer screening trial
T Mäkinen, TLJ Tammela, UH Stenman… - Clinical cancer …, 2004 - AACR
Purpose: Large randomized trials provide the only valid means of quantifying the benefits
and drawbacks of prostate-specific antigen (PSA) screening, but the follow-up of ongoing …
and drawbacks of prostate-specific antigen (PSA) screening, but the follow-up of ongoing …
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
MJ Roobol, R Kranse, CH Bangma, AG van Leenders… - European urology, 2013 - Elsevier
Background Evidence from randomized trials on the effects of screening for prostate cancer
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam
FH Schröder, R Raaijmakers, R Postma… - The Journal of …, 2005 - auajournals.org
ABSTRACT Purpose: The European Randomized Study of Screening for Prostate Cancer
investigates the impact of screening on prostate cancer mortality and contributes to a better …
investigates the impact of screening on prostate cancer mortality and contributes to a better …
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer …
FH Schröder, J Hugosson, S Carlsson, T Tammela… - European urology, 2012 - Elsevier
BACKGROUND: Metastatic disease is a major morbidity of prostate cancer (PCa). Its
prevention is an important goal. OBJECTIVE: To assess the effect of screening for PCa on …
prevention is an important goal. OBJECTIVE: To assess the effect of screening for PCa on …